PF-05212377
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-05212377, covering 2014-04-16 to 2017-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil [Phase 2]